322052 VO Nucleic Acid-Therapeutics: Antisense, RNA Interference, CRISPR - M14 (2017W)

1.00 ECTS (1.00 SWS), SPL 32 - Pharmazie

Beginn: 09.10.2017
Ende: 20.11.2017

Jeden Montag 16.30 - 18:00 Uhr im Raum 2D313

Moodle

Details

Language: German

Examination dates

Monday 13.11.2017

Lecturers

Johannes Winkler

Classes (iCal) - next class is marked with N

    
    Monday
    09.10.
    16:30 - 18:00
    Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
    
    Monday
    16.10.
    16:30 - 18:00
    Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
    
    Monday
    23.10.
    16:30 - 18:00
    Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
    
    Monday
    30.10.
    16:30 - 18:00
    Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
    
    Monday
    06.11.
    16:30 - 18:00
    Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
    
    Monday
    13.11.
    16:30 - 18:00
    Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
    
    Monday
    20.11.
    16:30 - 18:00
    Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II

Information

Aims, contents and method of the course

The course is mainly directed to advanced students of pharmacy or related curricula, and to doctoral students. Basic knowledge of biochemistry, pharmacology, and organic chemistry is required.

The course will be held in German.

Assessment and permitted materials

written examination
e-learning task

Minimum requirements and assessment criteria

Examination topics

Reading list

Association in the course directory

A400, MA23

Last modified: Sa 02.04.2022 00:27